Lakshmi S. Nayak

Neurology
450 Brookline Ave
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 139 publications

IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.

IGNITE: a phase III study of tirabrutinib versus rituximab and temozolomide combination therapy in relapsed/refractory primary central nervous system lymphoma.

Journal: Future oncology (London, England)
Published: June 19, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 22, 2026

Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.

Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study.

Journal: Journal of neuro-oncology
Published: January 19, 2026

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Evaluation of sex differences in survival among glioblastoma patients treated with immune checkpoint inhibitors.

Journal: Neuro-oncology advances
Published: October 24, 2025

Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.

Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.

Journal: Blood
Published: September 30, 2025

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Journal: Blood
Published: September 30, 2025

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma.

Journal: Neuro-oncology
Published: August 04, 2025

Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.

Clinical, molecular, and radiological predictors of prognosis in newly diagnosed astrocytoma, IDH-mutant, WHO grade 4.

Journal: Neuro-oncology
Published: May 29, 2025

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

Journal: Blood advances
Published: May 13, 2025

Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.

Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation-A progress report.

Journal: Neuro-oncology
Published: May 03, 2025

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.

Journal: Neuro-oncology
Published: April 28, 2025

Meeting Report From the 2024 Symposium on IRAK4 in Cancer: Highlights and Clinical Updates.

Meeting Report From the 2024 Symposium on IRAK4 in Cancer: Highlights and Clinical Updates.

Journal: Clinical lymphoma, myeloma & leukemia
Published: March 07, 2025
Showing 1-12 of 139

Last Updated: 09/26/2026